Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Hemostats Market: By Product: Combination, Thrombin-Based, Gelatin-Based, Collagen-Based, Oxidised Regenerated Cellulose Based; By Formulation; By Indication; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Hemostats Market Outlook
The global hemostats market is expected to grow at a CAGR of 6.4% in the forecast period of 2022-2027 to reach a value of approximately USD 5.2 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Number of Hospitals and Surgical Centres to Augment the Hemostats Industry Growth
Based on end use, hospitals account for a significant share in the hemostats industry. This can be attributed to its advanced consumer penetration and ease of care, especially in rural areas. In this case, hospitals have also proved to be a competent option. In addition, some of the major drivers for the hospital and surgical centres segment is projected to be the increasing focus on reducing surgical and post-surgical spending and the increasing prevalence of cardiovascular diseases.
The Asia Pacific Region to Provide Enhanced Growth Opportunities to the Hemostats Industry
Region-wise, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the high number of surgeries being conducted in the hospitals. The growth can also be attributed to the market expansion by the major players and the presence of significant untapped opportunities in the region. In addition, investment in the healthcare sector has gained momentum, especially in Japan, India, and China. These countries are increasingly focused on building comprehensive surgical clinics and recovery healthcare facilities. These variables are anticipated to contribute to the market growth in the coming years.
Hemostat: Market Segmentation
A hemostat (also called a hemostatic clamp, or arterial forceps) is a surgical device used to manage bleeding in certain surgical procedures. For this purpose, it is normal to be lined with hemostats that close blood vessels waiting for ligation in the initial phase of surgery for initial incision. Haemostats belong to a category of pivoting instruments (similar to scissors and include needle holders, tissue holders, and separate clamps) where the purpose is determined by the structure of the blade. The hemostat has handles, which, by their locking mechanism, can be kept in place.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is divided into:
- Combination
- Thrombin-Based
- Gelatin-Based
- Collagen-Based
- Oxidised Regenerated Cellulose Based
- Others
Based on formulation, the market is categorised into:
- Sheet and Pad
- Sponge
- Matrix and Gel
- Powder
- Others
On the basis of indication, the market is divided into:
- Surgery
- Wound Closure
- Others
Based on application, the market is segmented into:
- Cardiovascular Surgery
- General Surgery
- Gynaecological Surgery
- Orthopaedic Surgery
- Reconstructive Surgery
- Neurological Surgery
- Others
By end use, the market is categorised into:
- Clinics
- Hospitals
- Ambulatory Centres
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Prevalence of Chronic Diseases and a Surge in the Number of Surgical Procedures to Bolster the Growth of the Hemostats Industry
With the rise in people suffering from chronic diseases, the hemostats industry is at an all-time high. The citizens all over the world have shifted to a sedentary lifestyle which is leading to obesity, diabetes, and other lifestyle disorders. Furthermore, the increasing number of surgical procedures with the growing occurrence of trauma and accidents is also aiding the industry growth. The rise in poor lifestyle combined with the technological advancements in the healthcare sector is likely to increase the demand for hemostats, thus, significantly contributing to the market. Further, the reimbursement policies offered by the government has impacted the industry in a positive way. Over the forecast period, rise in demand for surgeries and the technological developments are expected to favour the industry growth.
Key Industry Players in the Global Hemostats Market
The report gives a detailed analysis of the following key players in the global hemostats market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Teleflex Incorporated
- B. Braun Melsungen AG
- Integra LifeSciences Corporation
- Pfizer Inc.
- Baxter International, Inc.
- Johnson & Johnson Services, Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Formulation, Indication, Application, End Use, Region |
| Breakup by Product | Combination, Thrombin-Based, Gelatin-Based, Collagen-Based, Oxidised Regenerated Cellulose Based, Others |
| Breakup by Formulation | Sheet and Pad, Sponge, Matrix and Gel, Powder, Others |
| Breakup by Indication | Surgery, Wound Closure, Others |
| Breakup by Application | Cardiovascular Surgery, General Surgery, Gynaecological Surgery, Orthopaedic Surgery, Reconstructive Surgery, Neurological Surgery, Others |
| Breakup by End Use | Clinics, Hospitals, Ambulatory Centres, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Teleflex Incorporated, B. Braun Melsungen AG, Integra LifeSciences Corporation., Pfizer Inc., Baxter International, Inc., Johnson & Johnson Services, Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Hemostats Market Analysis
8.1 Key Industry Highlights
8.2 Global Hemostats Historical Market (2017-2021)
8.3 Global Hemostats Market Forecast (2022-2027)
8.4 Global Hemostats Market by Product
8.4.1 Combination
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Thrombin-Based
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Gelatin-Based
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Collagen-Based
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.4.5 Oxidised Regenerated Cellulose Based
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2017-2021)
8.4.5.3 Forecast Trend (2022-2027)
8.4.6 Others
8.5 Global Hemostats Market by Formulation
8.5.1 Sheet and Pad
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Sponge
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Matrix and Gel
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Powder
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Others
8.6 Global Hemostats Market by Indication
8.6.1 Surgery
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Wound Closure
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Others
8.7 Global Hemostats Market by Application
8.7.1 Cardiovascular Surgery
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 General Surgery
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Gynaecological Surgery
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.7.4 Orthopaedic Surgery
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2017-2021)
8.7.4.3 Forecast Trend (2022-2027)
8.7.5 Reconstructive Surgery
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2017-2021)
8.7.5.3 Forecast Trend (2022-2027)
8.7.6 Neurological Surgery
8.7.6.1 Market Share
8.7.6.2 Historical Trend (2017-2021)
8.7.6.3 Forecast Trend (2022-2027)
8.7.7 Others
8.8 Global Hemostats Market by End Use
8.8.1 Clinics
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2017-2021)
8.8.1.3 Forecast Trend (2022-2027)
8.8.2 Hospitals
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2017-2021)
8.8.2.3 Forecast Trend (2022-2027)
8.8.3 Ambulatory Centres
8.8.3.1 Market Share
8.8.3.2 Historical Trend (2017-2021)
8.8.3.3 Forecast Trend (2022-2027)
8.8.4 Others
8.9 Global Hemostats Market by Region
8.9.1 Market Share
8.9.1.1 North America
8.9.1.2 Europe
8.9.1.3 Asia Pacific
8.9.1.4 Latin America
8.9.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country Kingdom
9.2.3.1 United
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Teleflex Incorporated
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 B. Braun Melsungen AG
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Integra LifeSciences Corporation.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Pfizer Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Baxter International, Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Johnson & Johnson Services, Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Hemostats Market: Key Industry Highlights, 2016 and 2026
2. Global Hemostats Historical Market: Breakup by Product (USD Billion), 2017-2021
3. Global Hemostats Market Forecast: Breakup by Product (USD Billion), 2022-2027
4. Global Hemostats Historical Market: Breakup by Formulation (USD Billion), 2017-2021
5. Global Hemostats Market Forecast: Breakup by Formulation (USD Billion), 2022-2027
6. Global Hemostats Historical Market: Breakup by Indication (USD Billion), 2017-2021
7. Global Hemostats Market Forecast: Breakup by Indication (USD Billion), 2022-2027
8. Global Hemostats Historical Market: Breakup by Application (USD Billion), 2017-2021
9. Global Hemostats Market Forecast: Breakup by Application (USD Billion), 2022-2027
10. Global Hemostats Historical Market: Breakup by End Use (USD Billion), 2017-2021
11. Global Hemostats Market Forecast: Breakup by End Use (USD Billion), 2022-2027
12. Global Hemostats Historical Market: Breakup by Region (USD Billion), 2017-2021
13. Global Hemostats Market Forecast: Breakup by Region (USD Billion), 2022-2027
14. North America Hemostats Historical Market: Breakup by Country (USD Billion), 2017-2021
15. North America Hemostats Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Europe Hemostats Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Europe Hemostats Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Asia Pacific Hemostats Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Asia Pacific Hemostats Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Latin America Hemostats Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Latin America Hemostats Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Middle East and Africa Hemostats Historical Market: Breakup by Country (USD Billion), 2017-2021
23. Middle East and Africa Hemostats Market Forecast: Breakup by Country (USD Billion), 2022-2027
24. Global Hemostats Market Structure
Key Questions Answered in the Report
The global hemostats market is projected to grow at a CAGR of 6.4% between 2022 and 2027.
The industry is primarily being driven by the growing cases of chronic conditions, sedentary lifestyle, improvements in the healthcare industry, increasing focus on reducing surgical and post-surgical spending, and the government's reimbursement policies.
The key trends leading the market forward are the expanding number of surgical operations and the increasing incidence of injuries and accidents.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific with the Asia Pacific accounting for the largest share in the market.
By product, the market is divided into combination, thrombin-based, gelatin-based, collagen-based, and oxidised regenerated cellulose based, among others.
Based on formulation, the market is categorised into sheet and pad, sponge, matrix and gel, and powder, among others.
On the basis of indication, the market is divided into surgery and wound closure, among others.
The major applications are cardiovascular surgery, general surgery, gynaecological surgery, orthopaedic surgery, reconstructive surgery, and neurological surgery, among others.
Hospitals segment is the dominant end-use in the industry.
The major players in the industry are Teleflex Incorporated, B. Braun Melsungen AG, Integra LifeSciences Corporation., Pfizer Inc., Baxter International, Inc., and Johnson & Johnson Services, Inc., among others.
Analyst Review
The global hemostats market is being driven by the rising prevalence of chronic conditions among people due to a sedentary lifestyle in the historical period. Aided by the growing technological advancements in the healthcare industry and the government's reimbursement policies, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 6.4%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the global hemostats industry can be segmented into combination, thrombin-based, gelatin-based, collagen-based, and oxidised regenerated cellulose based, among others. By formulation, the industry can be classified into sheet and pad, sponge, matrix and gel, and powder, among others. Based on indication, surgery and wound closure, among others are the major categories. On the basis of application, cardiovascular surgery, general surgery, gynaecological surgery, orthopaedic surgery, reconstructive surgery, and neurological surgery, among others are the major segments. By end-use clinics, hospitals, and ambulatory centres, among others are the primary sectors, with hospital segment accounting for the largest market share. The major regional markets for hemostats are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific, with the Asia Pacific accounting for the largest share of the market. The key players in the above market include Teleflex Incorporated, B. Braun Melsungen AG, Integra LifeSciences Corporation., Pfizer Inc., Baxter International, Inc., and Johnson & Johnson Services, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER